David Amsellem's
Stock Forecasts
11.11%
4/36 win trades
Price targets by David Amsellem
| Company name & ticker | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|
 Alkermes plc ALKS | 11 months ago | $37 27.58% upside | $31.25 | StreetInsider | Previous targets (0) |
 OptiNose, Inc. OPTN | 12 months ago | $1 -89.58% downside | $0.89 | StreetInsider | Previous targets (0) |
 Amneal Pharmaceuticals, Inc. AMRX | 12 months ago | $11 20.08% upside | $8.29 | StreetInsider | |
 Pacira BioSciences, Inc. PCRX | about 1 year ago | $12 -52.36% downside | $17.37 | StreetInsider | |
 Indivior PLC INDV | about 1 year ago | $15 -34.83% downside | $7.61 | StreetInsider | |
 Intra-Cellular Therapies, Inc. ITCI | about 1 year ago | $92 -30.23% downside | $72.42 | TheFly | Previous targets (0) |
 Neurocrine Biosciences, Inc. NBIX | about 1 year ago | $159 19.71% upside | $128.43 | StreetInsider | Previous targets (0) |
 Teva Pharmaceutical Industries Limited TEVA | about 1 year ago | $23 31.42% upside | $18.62 | StreetInsider | |
 Collegium Pharmaceutical, Inc. COLL | about 1 year ago | $37 -0.99% downside | $34.63 | StreetInsider | |
 Corcept Therapeutics Incorporated CORT | over 1 year ago | $38 -46.47% downside | $36.12 | StreetInsider | |
 Axsome Therapeutics, Inc. AXSM | over 1 year ago | $115 2.67% upside | $75.19 | StreetInsider | Previous targets (0) |
 Supernus Pharmaceuticals, Inc. SUPN | over 1 year ago | $41 -0.41% downside | $27.85 | StreetInsider | Previous targets (0) |
 Amphastar Pharmaceuticals, Inc. AMPH | over 1 year ago | $71 134.16% upside | $43.31 | StreetInsider | Previous targets (0) |
 Ironwood Pharmaceuticals, Inc. IRWD | over 1 year ago | $18 1537.85% upside | $6.82 | StreetInsider | Previous targets (0) |
 Revance Therapeutics, Inc. RVNC | over 1 year ago | $11 201.36% upside | $3.74 | StreetInsider | Previous targets (0) |
 Xeris Biopharma Holdings, Inc. XERS | over 1 year ago | $3 -59.02% downside | $1.85 | StreetInsider | Previous targets (0) |
 Bausch Health Companies Inc. BHC | over 1 year ago | $9 14.80% upside | $8.78 | StreetInsider | Previous targets (0) |
 Organon & Co. OGN | over 1 year ago | $24 158.62% upside | $18.85 | StreetInsider | Previous targets (0) |
 Aquestive Therapeutics, Inc. AQST | over 1 year ago | $10 157.73% upside | $4.07 | StreetInsider | Previous targets (0) |
 Viatris Inc. VTRS | over 1 year ago | $13 21.38% upside | $11.83 | StreetInsider | Previous targets (0) |
 Jazz Pharmaceuticals plc JAZZ | over 1 year ago | $188 56.99% upside | $124.79 | StreetInsider | Previous targets (0) |
Other analysts covering same stocks
Ashwani Verma
Bank of America Securities
100%
win rate
Covering:
Charles Duncan
Cantor Fitzgerald
40%
win rate